07:00 , Apr 30, 2009 |  BC Innovations  |  Distillery Therapeutics

Indication: Cardiovascular disease

This week in therapeutics Indication Target/marker/ pathway Summary Licensing status Publication and contact information Cardiovascular disease Cardiac hypertrophy; heart failure Calcium calmodulin-dependent kinase IIδ (CAMK2D); ryanodine receptor 2 (RyR2) Studies in mice suggest that targeting...